The HER2CLIMB-05 trial is a randomized, double blind, placebo-controlled, pivotal Phase 3 study evaluating the efficacy and safety of TUKYSA compared to placebo, both in combination with trastuzumab ...
NEW YORK-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 fourth-quarter 2026 dividend on the company’s common stock, payable December 7, 2026, ...
LITFULO significantly improved facial and total body repigmentation at Week 52 compared to placebo, with continuous improvement starting at Week 24, supporting planned regulatory filings for a ...
(NYSE: PFE) today presented detailed results from an ongoing Phase 2 study investigating tilrekimig (PF-07275315) in adults with moderate-t ...
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned ...
For Washington residents, please visit our Washington Health Data Privacy Policy to review our privacy practices related to your health data.
At Pfizer, interviews are a significant component of our hiring assessment process. The purpose of an interview is to get to know you better as a person, give you an opportunity to share your amazing ...
Pfizer believes that privacy is a fundamental right. Personal data is at the core of scientific and medical innovation, and your personal health data can play a critical role in helping you and your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results